Repare Therapeutics Inc.
NASDAQ:RPTX
Overview | Financials
Company Name | Repare Therapeutics Inc. |
Symbol | RPTX |
Currency | USD |
Price | 3.58 |
Market Cap | 151,954,890 |
Dividend Yield | 0% |
52-week-range | 2.71 - 8.49 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Lloyd Mitchell Segal |
Website | https://www.reparerx.com |
An error occurred while fetching data.
About Repare Therapeutics Inc.
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD